404
Participants
Start Date
November 27, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
treatment with or without colistin
For patients in this treatment group, colistin based therapy is used. Colistin combined with metroperan or imipenem（MIC≤8mg/L），or colistin combined with tigecycline, or colistin combined with aminoglycosides (amikacin) are suggested to treat patients diagnosed with hospital-acquired pneumonia or bloodstream infection caused by carbapenem-resistant enterobacteriaceae. For patients in the control, best available treatment without colistin is uesed; Ceftazidime-avibactam, tigecycline combined with metroperan or imipenem（MIC≤8mg/L）, tigecycline combined with aminoglycosides (amikacin) are suggested to treat patients diagnosed with hospital-acquired pneumonia or bloodstream infection caused by carbapenem-resistant enterobacteriaceae.
RECRUITING
Zhongda Hospital Affiliated to Southeast University, Nanjing
RECRUITING
Wuxi No.2 People's Hospital, Wuxi
RECRUITING
Yixing People's Hospital, Yixing
RECRUITING
Suzhou Municipal Hospitial, Suzhou
RECRUITING
The First Affiliated Hospital of Soochow University, Suzhou
RECRUITING
Xuzhou Central Hospital, Xuzhou
RECRUITING
The First Hospital of Lianyungang, Lianyungang
RECRUITING
Huai'an First People's Hospital, Huai'an
RECRUITING
Yancheng No.1 People's Hospital, Yancheng
RECRUITING
Northern Jiangsu People's Hospital, Yangzhou
RECRUITING
JiangsuTaizhou People's Hospital, Taizhou
RECRUITING
Affiliated Hospital of Nantong University, Nantong
RECRUITING
Anhui Provincial People's Hospital, Hefei
RECRUITING
The First Hospital of Anhui Medical University, Hefei
RECRUITING
Jinjiang Municipal Hospitall, Jinjiang
Southeast University, China
OTHER